Serum 25-hydroxyvitamin D in the VITamin D and OmegA-3 TriaL (VITAL): Clinical and demographic characteristics associated with baseline and change with randomized vitamin D treatment

The VITamin D and OmegA-3 TriaL (VITAL) is a completed randomized, placebo-controlled trial of vitamin D3 (2000  IU/day) and marine omega-3 (1 g/day) supplements in the primary prevention of cancer and cardiovascular disease. Here we examine baseline and change in 25-hydroxyvitamin D (25(OH)D) and related biomarkers with randomized treatment and by clinical factors.

Source: Contemporary Clinical Trials - October 23, 2019 Category: Radiology Authors: Heike Luttmann-Gibson, Samia Mora, Carlos A. Camargo, Nancy R. Cook, Olga V. Demler, Amit Ghoshal, Jay Wohlgemuth, Kris Kulkarni, Julia Larsen, James Prentice, Michael Cobble, Vadim Bubes, Chunying Li, Georgina Friedenberg, I-Min Lee, Julie E. Buring, JoA Source Type: research